Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-09-18

Clinical Trial Update: Effect of Benadryl Sedation During ERCP or EUS [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating sedation with Benadryl (diphenhydramine) during ERCP or EUS was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benadryl (diphenhydramine)

Snippet

Sponsor: University of Rochester | Conditions: Gallbladder Disease, Gallstones | Phase 1 | Status: WITHDRAWN